Methicillin-resistant Staphylococcus aureus versus the burn patient

Burns

Volumn 24, Issue 2, 1998, Pages 91-98

  Cook, Nicola ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Burn; Infection control; Methicillin resistant; MRSA; Staphylococcus aureus

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID; SULFADIAZINE SILVER; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BURN INFECTION; DISEASE TRANSMISSION; HOSPITAL; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 0032029405     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(97)00114-9     Document Type: Article

References (71)

1. [1] Cookson, B. and Phillips, I., Epidemic methicillin-resistant Staphylococcus aureus. J. Antimicrobial Chemother., 1988, 24 (supplement C), 57-65.
2. [2] Hackbarth, C. J. and Chambers, H. F., Methicillin-resistant staphylococci: genetics and mechanisms of resistance. Antimicrobial Agents Chemother., 1989, 33, 991-994.
3. [3] Khul, S. A., Pattee, P. A. and Baldwin, J. N., Chromosomal map location of the methicillin resistance determinant in Staphylococcus aureus. J. Bact., 1978, 135, 460-465.
4. [4] Beck, W. D., Berger-Bachi, B. and Kayser, F. H., Additional DNA in methicillin-resistant Staphylococcus aureus and molecular cloning of the mec-specific DNA. J. Bact., 1986, 165, 373-378.
5. [5] Matsubashi, M., Song, M. D. and Ishino, F. et al., Molecular cloning of the gene of a penicillin binding protein supposed to cause high resistance to β-lactam antibiotics in Staphylococcus aureus. J. Bact., 1986, 167, 975-980.
6. [6] Hartman, B. J. and Tomasz, A., Low affinity penicillin-binding protein associated with β-lactam resistance in Staphylococcus aureus. J. Bact., 1984, 158, 513-516.
7. [7] Kreiswirth, B., Kornblum, J. and Arbiet, R. D. et al., Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science, 1993, 259 (5092), 227-230.
8. [8] de Lacastre, H. and Tomsz, A., Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus. Antimicrobial Agents Chemother., 1994, 38, 2590-2598.
9. [9] Michel, M. and Gutman, L., Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet, 1997, 349, 1901-1907.
10. [10] Tomasz, A., Nachman, S. and Leaf, H., Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci. Antimicrobial Agents Chemother., 1991, 35, 124-129.
11. [11] Carles-Nurit, M. J., Christophle, B., Broche, S., Gouby, A., Bouziges, N. and Ramuz, M., DNA polymorphisms in methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus. J. Clin. Microbiol., 1992, 30 (8), 2092-2096.
12. [12] Branchini, M. L. M. Morthland, V. H. and Tresoldi, A. T., Nowakonski, A., Faller, M. A., Application of genomic DNA subtyping by pulse field gel electrophoresis and restriction enzyme analysis of plasmid DNA to characterize methicillin-resistant Staphylococcus aureus from two nosocomial outbreaks. Diagnostic Microbiol. Infect. Dis., 1993, 17, 275-281.
13. [13] Weekly Epidemiological Record. Methicillin-resistant Staphylococcus aureus (MRSA). Weekly Epidemiological Record No. 10 1996; 71(10), 73-78.
14. [14] Cookson, B. and Phillips, I., Methicillin-resistant staphylococci. J Appl. Microbiol., 1990, Symposium supplement, 55S-70S.
15. [15] Boyce, J. M., Landry, M., Deetz, T. R. and DuPont, H. L., Epidemiological studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections. Infect. Control., 1981, 2, 110-116.
16. [16] Hershow, R. C., Khayr, W. F. and Smith, N. L., A comparison of the clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect. Control Hosp. Epidemiol., 1992, 13, 587-593.
17. [17] Lacey, R. W., Multi-resistant Staphylococcus aureus: a suitable cause for inactivity. J. Hosp. Infect., 1987, 9, 103-105.
18. [18] Lacey, R. W., Barr, K. W., Barr, V. E. and Inglis, T. J., Properties of methicillin resistant Staphylococcus aureus colonising patients in a burns unit. J. Hosp. Infect., 1986, 7, 137-148.
19. [19] Barlow, Y., T lymphocytes and immunosuppression in the burned patient: a review. Burns, 1994, 20 (6), 487-490.
20. [20] Arturson, G., Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns, 1996, 22 (4), 255-274.
21. [21] Cetinkale, O., Cizmeci, O., Ayan, F., Senyuva, C. and Pusane, A., The use of FK506 and skin allografting for the treatment of severe burns in an animal model. Brit. J. Plastic Surg., 1993, 46 (5), 410-415.
22. [22] Donati, L .and Periti, P., Antibiotic treatment of burned patients: an Italian multicentre study. Intensive Care Med., 1994, 20, S30-S34.
23. [23] Mizobuchi, S., Minami, J., Jin, F., Matsushita, O. and Okabe, A., Comparison of the virulence of methicillin-resistant and methicillin-sensitive Staphylococcus aureus. Microbiol. Immunol., 1994, 38 (8), 599-605.
24. [24] Steer, J. A., Hill, G. B. and Wilson, A. P. R., The effect of burn wound surgery and teicoplanin on the bactericidal activity of polymorphonuclear leucocytes against Staphylococcus aureus. J. Antimicrobial Chemother., 1995, 36, 851-855.
25. [25] Duckworth, G. F. and Oppenheim, B. A., Enterotoxin production in epidemic methicillin resistant Staphylococcus aureus. Lancet, 1986, 1 (8480), 565-566.
26. [26] Townsend, C., Ashdown, N., Bolton, J., Duckworth, G., Moorhouse, EC and Grubb, W. B., The international spread of methicillin-resistant Staphylococcus aureus. J. Hospital Infect., 1987, 9, 60-71.
27. [27] Cookson, B. D., MRSA: major problem or minor threat. J. Med. Microbiol., 1993, 38, 309-310.
28. [28] Sheridan, R. L., Weber, J., Benjamin, J., Paternack, M. S. and Tomkins, R. G., Control of methicillin-resistant Staphylococcus aureus in a paediatric burn unit. Am. J. Infect. Control, 1994, 22 (6), 340-345.
29. [29] Morita, M. A., Methicillin-resistant Staphyhcoccus aureus -past present and future. Nurs. Clinics North Am., 1993, 28 (3), 625-637.
30. [30] Speller, D. C. E., Johnson, A. P. James, D., Marples, R. R., Charlett, A. and George, R. C., Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. The Lancet, 1997, 350, 323-325.
31. [31] Lesseva, M. I. and Hadjiiski, O. G., Staphylococcal infections in the Sofia Burn Centre, Bulgaria. Burns, 1996, 22 (4), 279-282.
32. [32] Suzuki, T., Ueki, I., Isago, T., Nozaki, M., Hirayama, T. and Kawanami, O., Multiple brain abscesses complicating treatment of severe burn injury: an unusual case report. J. Burn Care Rehabil., 1992, 13 (4), 446-450.
33. [33] Gang, R. K., Bajec, J., Krishna, J. and Sanyal, S. C., Unusual development of granulomas on the healing surface of burn wounds associated with MRSA infections. Burns, 1996, 22 (1), 57-61.
34. [34] Farrington, M., Ling, J., Ling, T. and French, G. L., Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital. Epidemiol. Infect., 1990, 105, 215-228.
35. [35] Hunt, J. L., Purdue, G. F. and Tuggle, D. W., Morbidity and mortality of an endemic pathogen: methicillin-resistant Staphylococcus aureus. Am. J. Surg., 1988, 156, 524-528.
36. [36] Thompson, R. L., Cabezudo, I. and Wenzel, R. P., Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Annals Internal Med., 1982, 97, 309-317.
37. [37] Matsumura, H., Yoshizawa, N., Narumi, A., Harunari, N., Sugamata, A .and Watanabe, K., Effective control of methicillin-resistant Staphylococcus aureus in a burn unit. Burns, 1996, 22 (4), 283-286.
38. [38] Witte, W., Braulke, C., Heuck, D. and Cuny, C., Analysis of nosocomial outbreaks with multiply and methicillin-resistant Staphylococcus aureus (MRSA) in Germany: implications for hospital hygiene. Infection, 1994, 22 (suppl. 2), S128-34.
39. [39] Haddad, Q., Sobayo, E. I., Basit, O. B. and Rotimi, V. O., Outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. J. Hosp. Infect., 1993, 23 (3), 211-222.
40. [40] Simpson, S., Methicillin resistant Staphylococcus aureus and its implications for nursing practice: a literature review. Nurs Practice, 1992, 5 (2), 2-7.
41. [41] Peacock, J. E., Marsick, F. J. and Wenzel, R. P., Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Annals Internal Med., 1980, 93 (4), 526-532.
42. [42] Mouton, R. P., Hermans, J. and Simoons-Smit, A. M., Hoogkamp-Korstaje, J. A., Degener, J. E. and Van-Kungeren, B., Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. J. Antimicrobial. Chemother., 1990, 26, 573-583.
43. [43] de Loulergue, J., Audurier, A., DeLarbre, J. M. and De Gailluly, C., Changes in microbial ecology and use of cloxicillin. J. Hosp. Infect., 1994, 27, 275-283.
44. [44] Asensio, A., Guerrero, A., Quereda, C., Lizan, M. and Martinez-Ferrer, M., Colonisation and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect. Control Hosp. Epidemiol., 1996, 17, 20-28.
45. [45] Pegg, S. P., Multiple resistant Staphylococcus aureus. Annals Acad. Med. Singapore, 1992, 22 (5), 664-666.
46. [46] Hansbrough, J., Wound healing: special considerations in the burn patient. Wounds, 1995, 7, A78-A83.
47. [47] Rode, H., de Wet, P. M., Millar, A. J. W. and Cywes, S., Bacterial efficiency of mupiricin in multi-antibiotic resistant Staphylococcus aureus burn wound infection. J. Antimicrobial. Chemother., 1988, 21, 589-595.
48. [48] Rode, H., Hanslo, D., de Wet, P. M., Millar, A. J. and Cywes, S., Efficacy of mupiricin in methicillin-resistant Staphylococcus aureus burn wound infection. Antimicrobial Agents Chemother, 1989, 33, 1358-1361.
49. [49] Capobianco, O. J., Doran, C. C. and Goldman, R. C., Mechanism of mupiricin transport into sensitive and resistant bacteria. Antimicrobial Agents Chemother., 1989, 33, 156-163.
50. [50] Vizcaino-Alcaide, M. J., Herruzo-Cabrera, R. and Rey-Calero, J., Efficacy of a broad spectrum antibiotic mupirocins in an in vitro model of skin infection. Burns, 1993, 19 (5), 392-395.
51. [51] Slocombe, B. and Perry, C., The antimicrobial activity of mupiricin - an update on resistance. J. Hosp. Infect., 1991, 29 (suppl. B), 19-25.
52. [52] Udo, E. E., Pearman, J. W. and Grubb, W. B., Emergence of high level mupiricin resistance in methicillin-resistant Staphylococcus aureus in Western Australia. J. Hosp. Infect., 1994, 26, 157-165.
53. [53] Gilbart, J., Perry, C. R. and Slocombe, B., High level mupiricin resistance in Staphylococcus aureus: evidence for two isoleucyl-tRNA synthetases. Antimicrobial Agents Chemother., 1993, 37, 32-38.
54. [54] Rodebeaver, G. T., Gentry, S., Saffer, L. and Edlich, R. F., Topical antimicrobial cream sensitivity testing. Surgery, Gynecol. Obstetrics, 1980, 151, 747-752.
55. [55] Smoot, E. C., Kucan, J. O., Graham, D. R. and Barenfanger, J. E., Susceptibility testing of topical antimicrobials against methicillin-resistant Staphylococcus aureus. J. Burn Care Rehabil., 1992, 13 (2 part 1), 198-202.
56. [56] Russell, A. D., Plasmid and bacterial resistance to biocides. J. Appl. Microbiol., 1997, 82, 155-165.
57. [57] Phillips, L. G., Meggers, J. P. and Robson, M. C., Burn and trauma units as sources of methicillin-resistant Staphylococcus aureus. J Burn Care Rehabilitation, 1992, 13, 293-297.
58. [58] Smith, D. J. and Thomson, P. D., Changing flora in burn and trauma units: historical perspective - experience in the United States. J. Burn Care Rehabil., 1992, 13 (2), 276-280.
59. [59] Noble, W. C., Virani, Z. and Cree, R. G,. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol. Lett., 1992, 72 (2), 195-198.
60. [60] Daum, R. S., Gupta, S., Sabbagh, R. and Milewski, W. M., Characterisation of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis., 1992, 166, 1066-1072.
61. [61] Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T. and Tenover, F. C., Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrobial Chemother., 1997, 40, 135-136.
62. [62] Promed-ahead Newsgroup. Staph. aureus, vancomycin resistance - Japan (06). Promed@usa.healthnet.org. 31 May 1997.
63. [63] Casewell, M. W., New threats to the control of methicillin-resistant Staphylococcus aureus. J. Hosp. Infect., 1995, 30 (Suppl.), 465-471.
64. [64] Rice, T. L., Simplified dosing and monitoring of vancomycin for the burn care clinician. Burns, 1992, 18 (5), 355-361.
65. [65] Walsh, T. J., Standiford, H. C. and Reboli, A. C. et al., Randomised double blinded trial of rifampicin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonisation: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrobial Agents Chemother., 1993, 37 (6), 1334-1342.
66. [66] Neu, H. C., The crisis in antibiotic resistance. Science, 1992, 257, 1064-1073.
67. [67] Daum, T. E., Schaberg, D. R., Terpinning, M. S., Sottile, W. S. and Kauffman, C. A., Increasing resistance of Staphylococcus aureus to ciprofloxicin. Antimicrobial Agents Chemother., 1990, 34, 1862-1863.
68. [68] Scheel, O., Lyon, D. J., Rosdahl, V. T., Adeyemi-Dora, F. A., Ling, T. K. and Cheng, A. F., In-vitro susceptibility of isolates of methicillin-resistant Staphylococcus aureus. J. Antimicrobial Chemother., 1996, 37 (2), 243-251.
69. [69] Ransjo, U., Malm, M., Hambraeus, A., Artursson, G. and Hedlund, A., Methicillin-resistant Staphylococcus aureus in two burns units: clinical significance and epidemiotogical control. J. Hospital Infect., 1989, 13, 355-365.
70. [70] Shirani, K. Z, McManus, A. T., Vaughan, G. M., McManus, W. F., Pruitt, B. A. and Mason, A. D,. Effects of environment on infection in burns patients. Arch. Surg., 1986, 121, 31-36.
71. [71] Mulligan, M. E., Murray-Leisure, K. A. and Ribner, B. S. et al., Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am. J. Med., 1993, 94 (3), 313-328.